Equity Profile

LH

Labcorp Holdings Inc.

Health CareHealth Care Services$22.7B

Apr30Thu

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:50 AM EDT

Labcorp Holdings Inc. Beats on EPS, Stock Down 0.13%

Metric	Actual	Expected	Surprise
EPS	$4.25	$4.12	+3.81%
Revenue	N/A	$3.5B	N/A

management commentary, guidance changes, and full analysis available with Pro.

Labcorp Holdings Inc. Beats on EPS, Stock Down 0.13%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$4.25	$4.12	+3.81%
Revenue	N/A	$3.5B	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

Labcorp's earnings report showed a positive surprise in EPS, indicating stronger-than-expected profitability. However, the stock reacted slightly negatively, declining by 0.13%. The lack of revenue data and management commentary may have contributed to investor uncertainty.

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostic solutions....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and performance, which investors closely watch.

$4.12

Revenue

Revenue figures provide insight into the company's overall sales performance and market demand.

$3.5B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostic solutions. With a market cap of $21 billion, it plays a crucial role in the health care sector, particularly as demand for testing and diagnostics continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.88%

Avg Stock Reaction

+1.95%

Last Quarter Recap

In the last quarter, Labcorp reported an EPS of $4.07, exceeding expectations by nearly 3%. However, the stock experienced a slight decline the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Labcorp to report solid earnings this quarter, with a consensus EPS of $4.12. Investors are particularly focused on revenue growth and any potential guidance from management.

Bull Case

If Labcorp exceeds EPS expectations and shows strong revenue growth, it could signal robust demand for its services, leading to a positive stock reaction.

Bear Case

Conversely, if the company misses EPS estimates or provides weak guidance, it could raise concerns about demand and profitability, negatively impacting the stock.

Key Metrics to Watch

EPS

$4.12

Earnings per share is a key indicator of profitability and performance, which investors closely watch.

Revenue

$3.5B

Revenue figures provide insight into the company's overall sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Labcorp's EPS exceed the consensus estimate of $4.12?

A beat on EPS could indicate stronger-than-expected profitability and boost investor confidence.

What guidance will management provide regarding revenue growth?

Management's outlook on revenue will be crucial for assessing future performance and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Labcorp's ability to leverage its diagnostic services amid rising health care demand, which could lead to stronger revenue growth than anticipated.

Supporting Evidence

The company's consistent EPS beats suggest a stronger operational performance than analysts expect.

Options pricing indicates a significant potential move, suggesting that the market is bracing for volatility.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on whether Labcorp can maintain its earnings momentum amid changing market conditions.

Bull Confirmed If

An EPS of $4.20 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $4.00 would support the bear case, raising concerns about demand.

Pre-Earnings Positioning

Options Market

Implied Move

±4.3%

Historical Avg

±4.2%

In line with history

The options market is pricing in a potential move of around 4.3%, indicating uncertainty about the earnings report.

Options are pricing ±4.3% while LH has averaged ±4.2% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.4%

30d HV

23.8%

Calls (600)P/C Ratio: 3.83Puts (3K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 7 of 23 (30%)

This setup has occurred 30 times across Health Care in the last 2 years. 16 of 23 (70%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 4.2%, with a raw directional average of +0.6% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Labcorp beats expectations, history suggests the stock could rise by around 1.39%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical data suggesting a potential drop of around 4.74%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

2 buys·0 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new diagnostic services or technology enhancements.
2Management's commentary on market demand and competitive landscape.
3Details on cost management and operational efficiencies.
4Guidance on future revenue growth and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Apr27

VZReported

Verizon Communications Inc.

Congress activity

RecapView

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostic solutions....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and performance, which investors closely watch.

$4.12

Revenue

Revenue figures provide insight into the company's overall sales performance and market demand.

$3.5B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.88%

Avg Stock Reaction

+1.95%

Last Quarter Recap

In the last quarter, Labcorp reported an EPS of $4.07, exceeding expectations by nearly 3%. However, the stock experienced a slight decline the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Labcorp to report solid earnings this quarter, with a consensus EPS of $4.12. Investors are particularly focused on revenue growth and any potential guidance from management.

Bull Case

If Labcorp exceeds EPS expectations and shows strong revenue growth, it could signal robust demand for its services, leading to a positive stock reaction.

Bear Case

Conversely, if the company misses EPS estimates or provides weak guidance, it could raise concerns about demand and profitability, negatively impacting the stock.

Key Metrics to Watch

EPS

$4.12

Earnings per share is a key indicator of profitability and performance, which investors closely watch.

Revenue

$3.5B

Revenue figures provide insight into the company's overall sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Labcorp's EPS exceed the consensus estimate of $4.12?

A beat on EPS could indicate stronger-than-expected profitability and boost investor confidence.

What guidance will management provide regarding revenue growth?

Management's outlook on revenue will be crucial for assessing future performance and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Labcorp's ability to leverage its diagnostic services amid rising health care demand, which could lead to stronger revenue growth than anticipated.

Supporting Evidence

The company's consistent EPS beats suggest a stronger operational performance than analysts expect.

Options pricing indicates a significant potential move, suggesting that the market is bracing for volatility.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on whether Labcorp can maintain its earnings momentum amid changing market conditions.

Bull Confirmed If

An EPS of $4.20 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $4.00 would support the bear case, raising concerns about demand.

Pre-Earnings Positioning

Options Market

Implied Move

±4.3%

Historical Avg

±4.2%

In line with history

The options market is pricing in a potential move of around 4.3%, indicating uncertainty about the earnings report.

Options are pricing ±4.3% while LH has averaged ±4.2% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.4%

30d HV

23.8%

Calls (600)P/C Ratio: 3.83Puts (3K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 7 of 23 (30%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Labcorp beats expectations, history suggests the stock could rise by around 1.39%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical data suggesting a potential drop of around 4.74%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

2 buys·0 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new diagnostic services or technology enhancements.
2Management's commentary on market demand and competitive landscape.
3Details on cost management and operational efficiencies.
4Guidance on future revenue growth and market expansion plans.